Pyridinyl imidazole compounds interfere with melanosomes sorting through the inhibition of Cyclin G-associated Kinase, a regulator of cathepsins maturation
Author:
Publisher
Elsevier BV
Subject
Cell Biology
Reference50 articles.
1. Protein kinases — the major drug targets of the twenty-first century?
2. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
3. Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase
4. Potentiation of cyclic AMP and cyclic GMP accumulation by p38 mitogen-activated protein kinase (p38MAPK) inhibitors in rat pinealocytes11Abbreviations: MAPK, mitogen-activated protein kinase; cAMP and cGMP, cyclic AMP and cyclic GMP, respectively; PKC, protein kinase C; IL-1β, interleukin-1β; IBMX, isobutylmethylxanthine; ISO, isoproterenol; PMA, 4β-phorbol 12-myristate 13-acetate; NE, norepinephrine; RIA, radioimmunoassay; DMEM, Dulbecco’s modified Eagle’s medium; PDE, phosphodiesterase; and CM, calmodulin.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inhibitory Effect of Chlorogenic Acid Analogues Comprising Pyridine and Pyrimidine on α-MSH-Stimulated Melanogenesis and Stability of Acyl Analogues in Methanol;Pharmaceuticals;2021-11-17
2. Identification of Key miRNAs in the Treatment of Dabrafenib-Resistant Melanoma;BioMed Research International;2021-04-05
3. Cepharanthine as a Potential Novel Tumor-Regional Therapy in Treating Cutaneous Melanoma: Altering the Expression of Cathepsin B, Tumor Suppressor Genes and Autophagy-Related Proteins;Frontiers in Bioengineering and Biotechnology;2020-12-01
4. Dual Targeting of BRAF and mTOR Signaling in Melanoma Cells with Pyridinyl Imidazole Compounds;Cancers;2020-06-10
5. Design and Synthesis of Novel 1-hydroxy-2,4,5-triaryl Imidazole Derivatives as Anti-cytokine Agents;IRAN J PHARM RES;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3